Back to ISIS Stock Lookup
Pages: 1 2 »» Last Page

ISIS – Analyst Ratings

Mar 31, 2014 11:32 AM ISIS Pharmaceuticals (ISIS) ApoCIII Continues to Show Unprecedented Lipid Benefits - BMO Capital
Mar 27, 2014 06:45 AM Activity of ISIS 560131/AZD5321 (ISIS) 'Incredibly Exciting' - BMO Capital
Mar 24, 2014 01:13 PM Arrowhead Research (ARWR): HBV Market Large Enough for Many Developers, says Deutsche Bank (ISIS)
Mar 10, 2014 02:52 PM Competitor Data Positive for ISIS Pharmaceuticals (ISIS), BMO Capital Says
Feb 24, 2014 11:07 AM Tekmira Pharma (TKMR) Jumps as Maxim Group Nearly Doubles Price Target
Feb 21, 2014 11:24 AM Needham & Company Ratchets Price Target on ISIS Pharmaceuticals (ISIS) to $61 on Positive Data
Feb 21, 2014 10:44 AM ISIS (ISIS) Data Encouraging; Infants Coming Soon, Says Deutsche Bank
Jan 22, 2014 06:43 AM Deutsche Bank Starts ISIS Pharmaceuticals (ISIS) at Buy
Nov 26, 2013 04:33 PM Piper Jaffray Upgrades ISIS Pharmaceuticals (ISIS) to Neutral
Oct 4, 2013 06:41 AM JPMorgan Starts ISIS Pharmaceuticals (ISIS) at Neutral
Sep 23, 2013 02:13 PM ISIS Pharmaceuticals (ISIS) PT Raised to $46 at Needham & Company on Positive Data
Sep 4, 2013 07:24 AM Goldman Sachs Starts ISIS Pharmaceuticals (ISIS) at Neutral; Sees 30% Downside if SMN-Rx Fails
Jul 23, 2013 06:45 AM Piper Jaffray Downgrades ISIS Pharmaceuticals (ISIS) to Underweight
Jul 22, 2013 08:17 AM Needham & Company Lifts PT on ISIS Pharmaceuticals (ISIS)
Jun 24, 2013 11:40 AM Needham & Company Boosts ISIS Pharmaceuticals (ISIS) PT to $29
Jun 24, 2013 10:56 AM ISIS Pharmaceuticals (ISIS) Results Called 'Stunning'
Jun 4, 2013 07:58 AM Needham & Company Upbeat on ISIS Pharmaceuticals (ISIS) Following ASCO
Mar 21, 2013 01:21 PM Analyst Cautiously Optimistic on ISIS (ISIS) SMN (Rx)
Nov 9, 2012 06:50 AM Cowen Upgrades ISIS Pharmaceuticals (ISIS) to Outperform
Oct 23, 2012 03:59 PM Isis Pharmaceuticals (ISIS) on Traders Radars Ahead of Cramer Mad Money Interview
Oct 19, 2012 01:43 PM Needham Reiterates Buy on ISIS (ISIS) Following Narrow FDA Vote for Approval of Kynamro
Oct 19, 2012 08:47 AM Jefferies Cuts Numbers on ISIS Pharmaceuticals (ISIS) Despite Panel Backing
Oct 17, 2012 09:28 AM Summer Street Cuts ISIS Pharmaceuticals (ISIS) to Neutral
Oct 16, 2012 09:08 AM Piper Jaffray Downgrades ISIS Pharmaceuticals (ISIS) to Overweight
Sep 6, 2012 06:56 AM JMP Securities Starts ISIS Pharmaceuticals (ISIS) at Market Perform
Aug 7, 2012 09:52 AM Canaccord Genuity Maintains Hold and Raises Price Target on ISIS Pharmaceuticals (ISIS)
Jul 19, 2012 07:18 AM Jefferies Downgrades ISIS Pharmaceuticals (ISIS) Two-Notches to Underperform
May 22, 2012 07:20 AM Needham & Company Starts ISIS Pharmaceuticals (ISIS) at Buy; Looking Beyond Kynamro at Significant Pipeline Value
May 9, 2012 09:55 AM Correction - Canaccord Genuity maintains a 'Hold' on ISIS Pharmaceuticals (ISIS)
May 9, 2012 09:52 AM Canaccord Genuity Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); Adjusting Estimates After Top & Bottom Line Beat
May 1, 2012 08:06 AM Piper Jaffray Upgrades ISIS Pharmaceuticals (ISIS) to Overweight
Mar 26, 2012 09:04 AM Canaccord Genuity Starts ISIS Pharmaceuticals (ISIS) at Hold
Nov 8, 2011 01:48 PM Jefferies Cuts Price Targets on ISIS Pharmaceuticals (ISIS), Has Enough Cash Through 2014
Sep 7, 2011 05:54 PM BMO Starts Biotech Stocks: AMGN, HGSI, REGN, CELG at Outperform, AMLN, GILD, ARNA at Market Perform, BIIB at Underperform
Aug 8, 2011 08:27 AM Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); 2Q11/Early 3Q11 Review - Mipomersen Application in EU (Submitted) and US (Expected by YE11)
Jun 28, 2011 07:56 AM Global Hunter Securities Starts Aegerion Pharmaceuticals (AEGR) at Buy; Lomitapide – A Potential Best-in-Class Drug
Apr 14, 2011 07:52 AM Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); Pipeline Progress Review – Long-Term, Early Stage Programs Are Encouraging
Mar 1, 2011 01:44 PM Barclays Maintains an 'Overweight' on ISIS Pharmaceuticals (ISIS); 4Q10 Update - Mipomersen Filings on Track
Mar 1, 2011 10:31 AM Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); Strong Focus on Mipomersen Next Steps by Genzyme, Steady Progress of Early-Stage Pipeline
Feb 17, 2011 10:34 AM Canaccord Genuity Morning Coffee on Sanofi-Aventis (SNY) and Genzyme (GENZ): An Extra $5 Will Help The Medicine Go Down
Jan 11, 2011 07:49 AM Needham & Company Reiterates a 'Hold' on ISIS Pharmaceuticals (ISIS); FDA Views Mipomersen Data as Sufficient to Submit HoFH NDA
Aug 5, 2010 09:51 AM Collins Stewart Downgrades ISIS Pharmaceuticals (ISIS) to Hold
Aug 5, 2010 08:43 AM Piper Jaffray Cuts Isis Pharma (ISIS) to Neutral
Aug 4, 2010 02:45 PM Shares of Isis Pharma (ISIS) Volatile Following Mid-Day Downgrade by Needham
Jul 27, 2010 09:37 AM Morgan Joseph Adds Onyx Pharma (ONXX) to 'Trading List' Following Positive Data on Carfilzomib
Jun 18, 2010 07:56 AM Needham & Company Reiterates a 'Buy' on ISIS Pharmaceuticals (ISIS), Well Positioned to Address Genetic Disorders
Jun 3, 2010 07:38 AM Needham & Company Reiterates a 'Buy' on ISIS Pharmaceuticals (ISIS); Annual Meeting Highlighted
May 28, 2010 01:08 PM Citi 2010 Healthcare Conference Key Takeaways - MRK, PFE, BMY, ISIS, NPSP, & MYGN
May 20, 2010 07:56 AM Needham & Company Reiterates a 'Buy' on ISIS Pharmaceuticals (ISIS); Pipelines to Address Cancer Through Antisense Technology
Apr 15, 2010 07:56 AM Needham & Company reiterates a 'Buy' on ISIS Pharmaceuticals (ISIS); Cardiovascular Program Update – Multiple Well-Characterized Drug Candidates
Pages: 1 2 »» Last Page

Back to ISIS Stock Lookup